Skip to main content

Politicians make promises on their stump — we watch and hold them accountable.

Help keep the record honest →Create an account
Fully KeptReproductive Rights

Pledged to keep fighting to ensure the FDA-approved abortion medication mifepristone remains available in Washington state.

Sources (click to view full provenance)

Propose an edit to this promise's details

Suggest a sourced correction to the promise text, topic, scope, significance, or dates. Changing the promise text requires a source. Your suggestion is reviewed before it changes the record.

Sign in and complete the Contributor Agreement to propose an edit.

Assessments

evidence-backed verdicts

These are sourced verdicts from fact-checkers or community evidence reviews — not opinions.

Fully KeptFact-checker reviewConfidence: 83%

Verified all three cited PRIMARY sources by WebFetch; every quote is accurate and every documented action supports the FULL rating for this "keep fighting" pledge. (1) Cantwell's Senate release (Jan 30, 2024) confirms the verbatim quote "The evidence overwhelmingly demonstrates that medication abortion is safe and effective, despite ongoing litigation led by anti-choice crusaders," confirms she JOINED 263 members (brief led by Murray, not her), and includes Washington-specific context ("More than half of the abortions provided in Washington state are medication abortions"). (2) The pharmacy-chains release (March 14, 2023) headline "Cantwell, Colleagues Call Out 7 Major Pharmacy Chains to Protect Access to FDA-Approved Abortion Pill" is verified verbatim, with WA-specific context (Walgreens in 65 WA communities, UW Medical Center press conference); Cantwell joined Murray and colleagues. (3) The Murray release title is verified and confirms Murray "Led 257 Members in Amicus Brief" — affirmatively corroborating that leadership belonged to Murray, so the promise is correctly NOT rated CHAMPIONED. Across these actions after the 2023-03-10 pledge, Cantwell sustained the promised fight through concrete, documented participation, and mifepristone remains available in Washington. The outcome is supported and not overstated; the non-CHAMPIONED downgrade is warranted because the sources show co-signing/participation, not personal leadership.

Your opinion on this assessment(clearly labeled opinion)

Sign in to vote.

Discussion

community opinions

Comments are user opinions — not verdicts. They do not affect the official assessment.

Sign in to join the discussion.

Propose a correction

community accountability

See an error in the promise text, status, significance, or missing source? Submit a sourced correction — a reviewer will evaluate and apply it if accurate. Your submission must cite evidence; unsourced changes are not accepted.

Sign in or create an account to propose a correction.

Debate

sourced community arguments

These are sourced community arguments — not StumpWatch assessments. Each cites a source and is community-contributed; it does not change the official status or rating above.

No arguments yet

Be the first to weigh in. Every argument cites a source and is reviewed before it publishes. Create an account to add one and help keep this promise honest.

Add a sourced argument

Cite a source for your point. Submissions are held for reviewer approval before they appear.

Sign in or create an account to add an argument.

StumpWatch is live, and the record is still growing. Many promises and positions aren’t tracked yet, and some features are still in beta. Add a sourced promise and help keep the record honest.

Help keep the record honest →